Select Page
PRF’s 2020 Newsletter!

PRF’s 2020 Newsletter!

As we all navigate this uncertain time, our fight against Progeria remains steadfast. PRF staff and the clinical trial team have been working closely with our Progeria families around the world, to ensure their continued access to PRF’s vital services. Our programs...
A Note to our PRF Community

A Note to our PRF Community

​First and foremost, we hope you are staying well. In light of the recent progression of COVID-19, and as we all navigate this uncertain time, we want to THANK YOU for your support and let you know that our fight against Progeria remains steadfast: PRF staff continue...
Application to FDA for lonafarnib approval is COMPLETE!

Application to FDA for lonafarnib approval is COMPLETE!

Application to FDA for lonafarnib approval is COMPLETE!    During an otherwise difficult time for our world, I am happy to share a bright spot: Eiger BioPharmaceuticals has completed submission of a New Drug Application (NDA), seeking approval – in Europe and...